General Information of the Compound
| Compound ID |
CP0567569
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-(1-benzylpiperidin-4-yl)-1-[4-[4-[4-(5-methyl-1H-indol-3-yl)butyl]piperazin-1-yl]phenyl]propan-1-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C38H48N4O
|
||||||||||||||||||
| Molecular Weight |
576.829
|
||||||||||||||||||
| Canonical SMILES |
Cc1ccc2[nH]cc(CCCCN3CCN(CC3)c3ccc(cc3)C(=O)CCC3CCN(Cc4ccccc4)CC3)c2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C38H48N4O/c1-30-10-16-37-36(27-30)34(28-39-37)9-5-6-20-40-23-25-42(26-24-40)35-14-12-33(13-15-35)38(43)17-11-31-18-21-41(22-19-31)29-32-7-3-2-4-8-32/h2-4,7-8,10,12-16,27-28,31,39H,5-6,9,11,17-26,29H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
GIUXWAMRUTVKNV-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00871, Sodium-dependent serotonin transporter